Showing results (11-20 of 379) with videos related to
Sort By:
Pageof 38
Cancer Clinical Trials|January 1, 1980
Pharmacokinetics of hypoxic cell radiosensitizers: a reviewP WorkmanCurrent Cancer Drug Targets|August 22, 2002
New drug targets for genomic cancer therapy: successes, limitations, opportunities and future challengesP WorkmanCancer Surveys|January 1, 1993
Pharmacokinetics and cancer: successes, failures and future prospectsP WorkmanBritish Journal of Cancer|September 1, 1979
Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in miceP WorkmanBiochemical Society Transactions|March 30, 2004
Inhibiting the phosphoinositide 3-kinase pathway for cancer treatmentP WorkmanCold Spring Harbor Symposia on Quantitative Biology|July 28, 2006
Drugging the cancer kinome: progress and challenges in developing personalized molecular cancer therapeuticsP WorkmanInternational Journal of Radiation Oncology, Biology, Physics|April 1, 1989
Micropharmacokinetics of chemical modifiersP WorkmanChemico-Biological Interactions|January 1, 1978
Inhibition of human prostatic tumour acid phosphatase by N,N-p-di-2-chloroethylaminophenol, N,N-p-di-2-chloroethylaminophenyl phosphate and other difunctional nitrogen mustardsP WorkmanCurrent Opinion in Pharmacology|November 17, 2001
Scoring a bull's-eye against cancer genome targetsP WorkmanCancer Chemotherapy and Pharmacology|January 1, 1980
Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in miceP WorkmanPageof 38